Photodynamic Therapy 2.0 DOI Creative Commons
Kyungsu Kang, Stefano Bacci

Biomedicines, Journal Year: 2024, Volume and Issue: 12(11), P. 2425 - 2425

Published: Oct. 22, 2024

In 1903, Von Tappeiner and Jesionek [...].

Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease DOI Creative Commons
Nikita Navolokin,

Viktoria Adushkina,

Daria Zlatogorskaya

et al.

Pharmaceuticals, Journal Year: 2024, Volume and Issue: 17(6), P. 788 - 788

Published: June 16, 2024

The COVID-19 pandemic, caused by infection with the SARS-CoV-2 virus, is associated cognitive impairment and Alzheimer’s disease (AD) progression. Once it enters brain, virus stimulates accumulation of amyloids in brain that are highly toxic to neural cells. These may trigger neurological symptoms COVID-19. meningeal lymphatic vessels (MLVs) play an important role removal toxins mediate viral drainage from brain. MLVs considered a promising target prevent COVID-19-exacerbated dementia. However, there limited methods for augmentation MLV function. This review highlights new discoveries field COVID-19-mediated amyloid development strategies stimulate clearance through other pathways. based on innovative treating dysfunction induced infection, including use photobiomodulation, plasmalogens, medicinal herbs, which offer hope addressing challenges posed virus.

Language: Английский

Citations

3

Recent Advances in Near-infrared Photobiomodulation for the Intervention of Acquired Brain Injury DOI Creative Commons

Yujing Huang,

Yujing Zhang,

Chen Yang

et al.

Journal of Innovative Optical Health Sciences, Journal Year: 2024, Volume and Issue: unknown

Published: July 19, 2024

Acquired brain injury (ABI) is an that affects the structure and function. Traditional ABI treatment strategies, including medications rehabilitation therapy, exhibit their ability to improve its impairments in cognition, emotion, physical activity. Recently, near-infrared (NIR) photobiomodulation (PBM) has emerged as a promising intervention method for ABI, demonstrating low-level light therapy can modulate cellular metabolic processes, reduce inflammation reactive oxygen species of microenvironments, promote neural repair regeneration. Preclinical studies using models have been carried out, revealing potential PBM promoting recovery although clinical application still early stages. In this review, we first inspected possible biological mechanisms NIR-PBM, then reported pathophysiology physiology underlying NIR-PBM intervention. Therefore, therapeutic was demonstrated it also expected further work facilitate applications.

Language: Английский

Citations

0

Photodynamic Therapy 2.0 DOI Creative Commons
Kyungsu Kang, Stefano Bacci

Biomedicines, Journal Year: 2024, Volume and Issue: 12(11), P. 2425 - 2425

Published: Oct. 22, 2024

In 1903, Von Tappeiner and Jesionek [...].

Citations

0